Pharmalot's Ed Silverman discusses the results of the National Pharmaceutical Council's recent survey on comparative effectiveness research and why, according to the data, the concept doesn't appear to be a "potent" one.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.